Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
Open Access
- 20 November 2009
- journal article
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 140
Abstract
Introduction: In liver stereotactic body radiotherapy, reduction of normal tissue irradiation requires daily image guidance. This is typically accomplished by imaging a surrogate to the tumor. The surrogate is often an implanted metal fiducial marker. There are few reports addressing the specific risks of hepatic fiducial marker implantation. These risks are assumed to be similar to percutaneous liver biopsies which are associated with a 1-4% complication rate - almost always pain or bleeding. To the best of our knowledge, we present the first case of such a fiducial marker migrating to the heart. Case presentation: An 81-year-old Caucasian man (5 years post-gastrectomy for a gastric adenocarcinoma) was referred post-second line palliative chemotherapy for radiotherapy of an isolated liver metastasis. It was decided to proceed with treatment and platinum fiducials were chosen for radiation targeting. Under local anesthesia, three Nester embolization coils (Cook Medical Inc., Bloomington, IN, USA) were implanted under computed tomography guidance. Before the placement of each coil, the location of the tip of the delivery needle was confirmed by computed tomography imaging. During the procedure, the third coil unexpectedly migrated through the hepatic vein to the inferior vena cava and lodged at the junction of the vena cava and the right atrium. The patient remained asymptomatic. He was immediately referred to angiography for extraction of the coil. Using fluoroscopic guidance, an EN Snare Retrieval System (Hatch Medical L.L.C., Snellville, GA, USA) was introduced through a jugular catheter; it successfully grasped the coil and the coil was removed. The patient was kept overnight for observation and no immediate or delayed complications were encountered due to the migration or retrieval of the coil. He subsequently went on to be treated using the remaining fiducials. Conclusion: Implanted fiducial markers are increasingly used for stereotactic radiotherapy. There is sparse literature on the risks of such procedures. Although uncommon, the risk of migration does exist and therefore physicians (surgeons, oncologists and radiologists) and patients should be aware of this possibility.Keywords
This publication has 13 references indexed in Scilit:
- Use of Platinum Embolization Coils for Targeting Liver Lesions in Stereotactic Body Radiotherapy/Radiosurgery2010
- Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation TherapyJournal of Vascular and Interventional Radiology, 2009
- Ultrasound-Guided Transrectal Implantation of Gold Markers for Prostate Localization During External Beam Radiotherapy: Complication Rate and Risk FactorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Percutaneous Liver Biopsy Is Safe in Chronic Hepatitis C Patients With End-Stage Renal DiseaseClinical Gastroenterology and Hepatology, 2007
- Versatility of the Novalis System to Deliver Image-Guided Stereotactic Body Radiation Therapy (SBRT) for Various Anatomical SitesTechnology in Cancer Research & Treatment, 2007
- Stereotactic Body Radiation Therapy in Multiple Organ SitesJournal of Clinical Oncology, 2007
- Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT)Radiotherapy and Oncology, 2002
- Stereotactic Radiotherapy of Malignancies in the Abdomen: Methodological aspectsActa Oncologica, 1994
- Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988